Get startedLog in
    Picture of Isofol Medical AB (publ) logo

    ISOFOL — Isofol Medical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Isofol Receives Recommendation From iDSMB To Complete The Global Phase III Agent Study For Market Registration As Planned With 440 Patients

    Picture of Isofol Medical AB (publ) logoIsofol Medical AB (publ)
    19/03/2021 17:15
    March 19 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * RECEIVES RECOMMENDATION FROM IDSMB TO COMPLETE THE GLOBAL
PHASE
III AGENT STUDY FOR MARKET REGISTRATION AS PLANNED WITH 440
PATIENTS
    * EXPECTS TOP LINE RESULTS FOR AGENT STUDY TO BE AVAILABLE
DURING
H1 2022

Source text for Eikon:  ID:nWkrbtKsp6 
Further company coverage:  ISOFOL.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Isofol Medical AB (publ)

    See all news